ClinicalTrials.gg
RecruitingNCT07674043Updated Oct 23, 2026

MY01 Pressure Monitoring in Adolescent Tibia Fractures

An interventional study of Continuous Compartmental Pressure Monitor in Proximal Tibia Fracture, Tibial Shaft Fracture and Acute Compartment Syndrome, sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 10 Years to 21 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 23, 2026Study contact changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
10 Years to 21 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.

Planned enrollment
20th of 38
50 · median 53
Started
2026
the only one that year
No phase
27 of 50
10 open now
Primary completion
2028-06
later than 13 of 17 live
Registered
49th of 50
by date

Among the 50 studies in Tibial Fractures with a site in United States, this one is the 20th largest by planned enrollment of the 38 interventional ones that give a count, is the only one that started in 2026, is one of 27 with no phase, reaches primary completion later than 13 of the 17 other live ones, and was the 49th registered.

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

Browse Tibial Fractures studies →

Open to participants now

15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 10 Years to 21 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Tibial Fractures with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn more about anterior leg compartment pressures in adolescents who have sustained tibia fractures. It will also examine whether measuring anterior compartment pressure helps physicians diagnose acute compartment syndrome (ACS), a rare but dangerous complication that can develop following surgical treatment of a tibia fracture.

The main questions it aims to answer are:

  1. Are there differences in anterior compartment pressures between healthy patients and patients who develop ACS?
  2. Does compartment pressure monitoring aid physicians in accurately diagnosing ACS?

Participants will have a continuous pressure monitoring sensor placed in their knee anterior knee compartment during their surgery. This sensor will record pressure data following a patient's surgical treatment for 18+ hours.

03

Conditions studied

  • Proximal Tibia Fracture
  • Tibial Shaft Fracture
  • Acute Compartment Syndrome

Browse trials for

Keywords

  • Tibia fracture
  • acute compartment syndrome
  • compartment pressure
  • pediatric
04

Who can participate

Ages eligible
10 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 10 to 21 on the day of surgery
  • Undergoing operative fixation for a fracture of the proximal tibia or tibial shaft

Exclusion criteria

Exclusion Criteria:

  • Preoperative diagnosis of acute compartment syndrome
  • Preexisting neuromuscular or vascular condition affecting the injured extremity
  • MY01 device malfunction
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    MY01

    All study participants will have an MY01 medical device inserted to record continuous anterior compartment pressure data.

    Device: Continuous Compartmental Pressure Monitor

Interventions

  • DeviceContinuous Compartmental Pressure Monitor

    All study participants will have a continuous compartmental pressure monitor placed in the operating room. The pressure sensor will be inserted into the anterior knee compartment, and will remain in place for a minimum of 18 hours postoperatively.

06

What researchers measure

Primary outcomes

  1. Continuous anterior compartment pressure

    The primary outcome will be continuous anterior compartment pressure measurements, recorded in millimeters of mercury (mmHg) by the MY01 device.

    Time frame: From the placement of the MY01 device sensor to 18 hours postoperatively

Secondary outcomes

  1. Development of acute compartment syndrome

    The secondary outcome will be the development of acute compartment syndrome, defined as a clinically diagnosed ACS requiring surgical fasciotomy during index hospitalization. This outcome will be analyzed as a binary variable.

    Time frame: From MY01 device insertion to index hospital discharge, up to 1 week postoperatively

Other outcomes

  1. Neurovascular status

    The third outcome will be clinical neurovascular status at the initial postop visit. This will be defined as a well-perfused limb with normal distal motor and sensory function as described in the clinical note. This outcome will be analyzed as a binary variable (normal neurovascular status or abnormal neurovascular status). Abnormal neurovascular status will subsequently be defined as the presence of any of the following: abnormal motor function, abnormal sensory function, and/or abnormal vascular status.

    Time frame: First clinic visit following hospital discharge, average of 2-4 weeks postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jun 2028, 21 months after the start.

Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 21 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 29, 2026
StartActual
Aug 17, 2026
Primary completionEst.
Jun 1, 2028
CompletionEst.
Jun 1, 2028
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Contact
Study contact changed: s•••@childrens.harvard.edu · •••6000→l•••@childrens.harvard.edu · •••1827. See the current contact
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Contact Study contact changed: s•••@childrens.harvard.edu · •••6000→l•••@childrens.harvard.edu · •••1827. See the current contact

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07674043
Responsible party
Kristin Livington (Principal Investigator, Boston Children's Hospital) — Principal investigator
First posted
Jun 29, 2026
Start date
Aug 17, 2026
Primary completion
Jun 1, 2028 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Oct 23, 2026

Study contacts

Kristin Livingston, MD
Contact
kristin.livingston@childrens.harvard.edu
617-355-6021
Libby Szewczak, BS
Contact
libby.szewczak@childrens.harvard.edu
617-355-1827
Kristin Livingston, MD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion